Zelira Therapeutics (AU:ZLD) has released an update.
Zelira Therapeutics announced that all resolutions were successfully passed at their recent Annual General Meeting, showcasing strong shareholder support. The resolutions included key decisions such as the re-election of directors and the approval of a 10% placement capacity. This outcome reflects a positive sentiment towards the company’s strategic direction and governance.
For further insights into AU:ZLD stock, check out TipRanks’ Stock Analysis page.
